Copyright Reports & Markets. All rights reserved.

Global Whole Genome Amplification Market Research Report 2019

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Whole Genome Amplification Industry
  • 1.7 COVID-19 Impact: Whole Genome Amplification Market Trends
  • 2 Global Whole Genome Amplification Quarterly Market Size Analysis

    • 2.1 Whole Genome Amplification Business Impact Assessment - COVID-19
      • 2.1.1 Global Whole Genome Amplification Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Whole Genome Amplification Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Whole Genome Amplification Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Whole Genome Amplification Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Whole Genome Amplification Market
    • 3.4 Key Players Whole Genome Amplification Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Whole Genome Amplification Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Single Cell WGA Kit
      • 1.4.2 Complete WGA Kit
      • 1.4.3 WGA Reamplification Kit
      • 1.4.4 WGA & Chip DNA Kit
      • 1.4.5 Others
    • 4.2 By Type, Global Whole Genome Amplification Market Size, 2019-2021

    5 Impact of Covid-19 on Whole Genome Amplification Segments, By Application

    • 5.1 Overview
      • 5.5.1 Drug Discovery & Development
      • 5.5.2 Disease Diagnosis
      • 5.5.3 Agriculture & Veterinary
      • 5.5.4 Research
      • 5.5.5 Forensics
      • 5.5.6 Others
    • 5.2 By Application, Global Whole Genome Amplification Market Size, 2019-2021
      • 5.2.1 By Application, Global Whole Genome Amplification Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Sigma-Aldrich
      • 7.1.1 Sigma-Aldrich Business Overview
      • 7.1.2 Sigma-Aldrich Whole Genome Amplification Quarterly Revenue, 2020
      • 7.1.3 Sigma-Aldrich Whole Genome Amplification Product Introduction
      • 7.1.4 Sigma-Aldrich Response to COVID-19 and Related Developments
    • 7.2 QIAGEN NV
      • 7.2.1 QIAGEN NV Business Overview
      • 7.2.2 QIAGEN NV Whole Genome Amplification Quarterly Revenue, 2020
      • 7.2.3 QIAGEN NV Whole Genome Amplification Product Introduction
      • 7.2.4 QIAGEN NV Response to COVID-19 and Related Developments
    • 7.3 GE Healthcare
      • 7.3.1 GE Healthcare Business Overview
      • 7.3.2 GE Healthcare Whole Genome Amplification Quarterly Revenue, 2020
      • 7.3.3 GE Healthcare Whole Genome Amplification Product Introduction
      • 7.3.4 GE Healthcare Response to COVID-19 and Related Developments
    • 7.4 LGC Group
      • 7.4.1 LGC Group Business Overview
      • 7.4.2 LGC Group Whole Genome Amplification Quarterly Revenue, 2020
      • 7.4.3 LGC Group Whole Genome Amplification Product Introduction
      • 7.4.4 LGC Group Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Whole Genome Amplification, including the following market information:
      Global Whole Genome Amplification Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Whole Genome Amplification Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Whole Genome Amplification Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Whole Genome Amplification Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Sigma-Aldrich, QIAGEN NV, GE Healthcare, LGC Group, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Single Cell WGA Kit
      Complete WGA Kit
      WGA Reamplification Kit
      WGA & Chip DNA Kit
      Others

      Based on the Application:
      Drug Discovery & Development
      Disease Diagnosis
      Agriculture & Veterinary
      Research
      Forensics
      Others

      Buy now